Company / Return on Equity (ROE)
QuidelOrtho Return on Equity (ROE) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-58.9%
FY2025
5-year range
-68.8% / 11.1%
FY2022-FY2025
Trend
+14.3%
vs FY2024
Sector context
#140 of 147
Health Care
What the data says
QuidelOrtho reports negative total equity of -58.9% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-58.9% in FY2025 with a 3-year CAGR of -70.0%.
Declined from -0.2% to -58.9% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -70.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 147This company -58.9% Sector average -3.1%
▼
-1788.4% below sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 14.3% year-over-year.
- Currently 55.8pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 0.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -58.9% | +14.3% |
| FY2024 | -68.8% | -34280.0% |
| FY2023 | -0.2% | -101.8% |
| FY2022 | 11.1% | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026